OvaScience Inc names Dr. Hugh Taylor to Scientific Advisory Board
Oct 25, 2013 (M2 EQUITYBITES via COMTEX) --
Life sciences company OvaScience Inc (NasdaqGM:OVAS) revealed on Thursday the election of Dr. Hugh Taylor, M.D. to its Scientific Advisory Board.
In conjunction with the appointment, the company has signed a research collaboration with Dr. Taylor's team to develop potential new treatments and diagnostic markers for endometriosis, a leading cause of female infertility.
Currently, Dr. Taylor is the Anita O'Keeffe Young Professor of Obstetrics, Gynecology, and Reproductive Sciences and Professor of Molecular, Cellular, and Developmental Biology at the Yale School of Medicine and Chief of Obstetrics and Gynecology, Yale-New Haven Hospital. He is the Editor-in-Chief of Reproductive Sciences.
Dr. Taylor was recognized by the IVI Foundation for the best research in reproductive medicine in 2013 and was named Honoree of the Year by the Endometriosis Foundation in 2012.
The company added Dr. Taylor brings to his new role more than 25 years of experience as a clinician and researcher in reproductive medicine, with focus on stem cells, uterine development and endometriosis.
Comments on this story may be sent to email@example.com
[ Back To Technology News's Homepage ]